Skip to main content
. Author manuscript; available in PMC: 2026 Sep 3.
Published before final editing as: Prev Med. 2026 Aug 20:108650. doi: 10.1016/j.ypmed.2026.108650

Table 1.

Participant characteristics of syringe service program recipients with stimulant use disorder in Burlington, Vermont between 02/24–07/24, overall and by treatment condition.

Variable All Participants (n = 27) Health Education + CM for Session Attendance Condition (n = 13) Health Education + CM for Stimulant Abstinence Condition (n = 14) p- valuea

mean SD mean SD mean SD
Mean age (years) 41.8 7.7 40.1 6.1 43.4 8.8 0.27
n % n % n %
Gender 0.18
Female 16 59.3 6 46.2 10 71.4
Male 11 40.7 7 53.8 4 28.6
Race/Ethnicity 0.51
Non-Hispanic White 23 85.2 11 84.6 12 85.7
Non-Hispanic, > 1 race 3 11.1 2 15.4 1 7.1
Hispanic, > 1 race 1 3.7 0 0.0 1 7.1
Primary Drug 0.48
Cocaine 10 37.0 4 30.8 6 42.9
Methamphetamine 8 29.6 3 23.1 5 35.7
Cocaine & heroin/fentanyl 3 11.1 2 15.4 1 7.1
Methamphetamine & heroin/fentanyl 3 11.1 2 15.4 1 7.1
Heroin/fentanyl 2 7.4 2 15.4 0 0.0
Not reported 1 3.7 0 0.0 1 7.1
Injection Drug Use 0.47
Yes 19 70.4 10 76.9 9 64.3
Reported Fentanyl Use 0.47
Yes 19 70.4 10 76.9 9 64.3
Current Treatment
Medication for opioid use disorder 22 81.5 10 76.9 12 85.7 0.65
Outpatient 3 11.1 2 15.4 1 7.1 0.60
12-step/recovery group 3 11.1 2 15.4 1 7.1 0.60
None 3 11.1 2 15.4 1 7.1 0.60
Past Year Treatment
Medication for opioid use disorder 24 88.9 11 84.6 13 92.9 0.60
Outpatient 5 18.5 3 23.1 2 14.3 0.65
Inpatient 3 11.1 1 7.7 2 14.3 1.00
12-step/recovery group 3 11.1 2 15.4 1 7.1 0.60
None 3 11.1 2 15.4 1 7.1 0.60
Housing Status 0.40
Unhoused/Unstable 20 74.1 11 84.6 9 64.3
Permanent 6 22.2 2 15.4 4 28.6
Not reported 1 3.7 0 0.0 1 7.1
Employment Status 0.45
Unemployed 16 59.3 9 69.2 7 50.0
Disability 8 29.6 3 23.1 5 35.7
Part-time work 1 3.7 0 0.0 1 7.1
Full-time work 1 3.7 1 7.7 0 0.0
Other 1 3.7 0 0.0 1 7.1
Jail or Prison in Last 12 Months 0.17
Yes 6 22.2 1 7.7 5 35.7

Notes:

a

p-values based on two-sample t-tests, Fisher’s exact tests, and χ2 tests. CM = contingency management.